Bioanalytical Solutions for Biomarkers
Altasciences supports both preclinical and clinical studies covering many disease indications, such as oncology, metabolic disease, neurology, diabetes, inflammation, and more. Our integrated approach involves bringing in toxicologists and clinical pharmacologists to develop a comprehensive preclinical to clinical plan to maximize the translation of results from one phase to the next.
We will help guide you towards a robust and effective biomarker solution, using state-of-the-art technologies that include:
- Mass spectrometry
- Flow cytometry
- Cell-based assays
- Immunoassays
- Quantitative PCR
- Immunohistochemistry
Discover the difference.
Questions? Speak with our scientists.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
You may also be interested in the following:
Setting the Foundation for Quality and Expertise in Drug Manufacturing
With the manufacturing and analytical capabilities to produce Schedule I to V products, Altasciences helps you accelerate your drug development program without compromising quality.
In this interview, Ben W. Reed, Vice President of Manufacturing, discusses Altasciences' unique drug manufacturing capabilities, talent acquisition, and running niche programs.
Do you have questions? Speak to an expert.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether a single service or a synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept and beyond.
You may also be interested in the following:
- On-Demand Webinar: Liquid-filled Capsule Expertise
- Case Study: Altasciences Fills Need of Leading Cancer Therapeutic Drug Developer
- Video Podcast: Overview of Manufacturing Capabilities
Over 20 Years of Bioanalytical Expertise
From discovery to preclinical to Phase IV, our team of over 200 highly skilled bioanalytical experts are ready to help you with your bioanalytical needs.
We deliver world-leading science, proven data integrity, regulatory expertise, and use state-of-the-art instrumentation to support both small and large molecule bioanalytical programs, including:
- Small and large molecule LC-MS/MS
- Microsampling
- Ligand binding assays
- Cell-based assays
- Biomarker quantitation
- Immunogenicity assessments
- Kit preparation
Find out more about how Altasciences can help you with your bioanalytical needs.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept.
You may also be interested in the following:
Premier Service Provider for Driving Simulator Clinical Trials
With over 13,000 simulated drives to date and the ability to accommodate up to 20 driving simulators on-site at once, Altasciences is the ideal full-service provider for your driving simulator clinical trials.
You can gather accurate driving performance data comparable in sensitivity to over-the-road testing, with faster study startup, lower cost, no risk of property damage, and no risk of injuries.
When working with Altasciences, you benefit from:
- A large database of study participants for ease of recruitment
- Professional oversight by fullycertified, in-house driving simulation study specialists
- Advanced 3D graphics that generate realistic representations of driving environment
- Automated measurement of psychomotor functioning, divided attention, situational awareness, and other cognitive behaviors
Click here for more in-depth information about our driving simulator capabilities, or contact our experts to discuss.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept and beyond.
You may also be interested in the following:
The Altascientist: FDA Finalizes Drug-Impaired Driving Guidance
Video: Driving Simulation Studies
Fact sheet: Driving Simulation Studies
Overcoming Bioanalytical Challenges with ADA Assays
In recent years, there has been an increase in approved monoclonal antibodies for the treatment of a variety of diseases. The complex nature of these larger molecules generates unwanted immunogenicity that targets the therapeutic drug, impacting its safety and efficacy profile. At Altasciences, our technology and bioanalytical methods are constantly evolving to achieve highly sensitive and robust ADA assays. Our scientific experts understand the importance of putting into context the clinical relevance of the study to ensure the success of your drug product.
In this issue of The Altascientist, see how we overcome the challenges faced when evaluating ADA assays.
Contact our experts to learn more about our large molecule expertise.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept.